1.69
price down icon1.17%   -0.02
after-market アフターアワーズ: 1.66 -0.03 -1.78%
loading
前日終値:
$1.71
開ける:
$1.74
24時間の取引高:
334.35K
Relative Volume:
0.96
時価総額:
$52.72M
収益:
$1.05M
当期純損益:
$-48.82M
株価収益率:
-0.9235
EPS:
-1.83
ネットキャッシュフロー:
$-47.49M
1週間 パフォーマンス:
+7.64%
1か月 パフォーマンス:
+12.67%
6か月 パフォーマンス:
+30.00%
1年 パフォーマンス:
-76.23%
1日の値動き範囲:
Value
$1.67
$1.79
1週間の範囲:
Value
$1.49
$1.79
52週間の値動き範囲:
Value
$1.06
$8.64

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Name
名前
Actinium Pharmaceuticals Inc
Name
セクター
Healthcare (1161)
Name
電話
646-767-3870
Name
住所
275 Madison Avenue, 7th Floor, New York, NY
Name
職員
25
Name
Twitter
@actiniumpharma
Name
次回の収益日
2025-03-14
Name
最新のSEC提出書
Name
ATNM's Discussions on Twitter

ATNM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ATNM
Actinium Pharmaceuticals Inc
1.69 48.98M 1.05M -48.82M -47.49M -1.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-07 ダウングレード B. Riley Securities Buy → Neutral
2024-05-14 開始されました Stephens Overweight
2023-09-06 開始されました HSBC Securities Buy
2023-02-21 ダウングレード William Blair Outperform → Mkt Perform
2022-09-08 開始されました Cantor Fitzgerald Overweight
2022-08-25 開始されました B. Riley Securities Buy
2020-11-05 開始されました Alliance Global Partners Buy
2017-12-06 開始されました B. Riley FBR, Inc. Buy
2017-10-23 再開されました ROTH Capital Buy
2017-09-14 開始されました Maxim Group Buy
2016-08-25 開始されました ROTH Capital Buy
2016-02-29 開始されました H.C. Wainwright Buy
2015-10-15 開始されました FBR Capital Outperform
2014-10-01 開始されました MLV & Co Buy
2014-07-22 開始されました Canaccord Genuity Buy
すべてを表示

Actinium Pharmaceuticals Inc (ATNM) 最新ニュース

pulisher
Jul 21, 2025

What drives Actinium Pharmaceuticals Inc. stock priceExponential return rates - Autocar Professional

Jul 21, 2025
pulisher
Jul 19, 2025

What analysts say about Actinium Pharmaceuticals Inc. stockBreakthrough capital growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Actinium Pharmaceuticals Inc. Stock Analysis and ForecastExtraordinary market timing - Jammu Links News

Jul 19, 2025
pulisher
Jul 18, 2025

Is Actinium Pharmaceuticals Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 15, 2025

Why Actinium Pharmaceuticals Inc. stock attracts strong analyst attentionFree Exclusive Access to Stock Gurus - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Actinium Pharmaceuticals Inc. stock performs during market volatilityRisk Managed Trading Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Actinium Pharmaceuticals Inc. stock price move sharplyFree Investment Group - Newser

Jul 15, 2025
pulisher
Jul 02, 2025

Actinium Highlights ATNM 400 Progress at SNMMI Conference - Yahoo.co

Jul 02, 2025
pulisher
Jun 30, 2025

Actinium’s ATNM-400 demonstrates superior efficacy in prostate cancer - BioWorld MedTech

Jun 30, 2025
pulisher
Jun 23, 2025

Innovative Prostate Cancer Treatment ATNM-400 Shows Promising Pr - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medic - Yahoo Finance

Jun 23, 2025
pulisher
Jun 19, 2025

Investigation announced for Long-Term Investors in shares - openPR.com

Jun 19, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $148,000 Stake in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm - PR Newswire

Jun 10, 2025
pulisher
Jun 08, 2025

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Acquired by Squarepoint Ops LLC - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Increases Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for InvestorsContact The Gross Law Firm - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Actinium Pharmaceuticals, Inc. to Contact the Firm Today! - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 03, 2025

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Purchased by Deutsche Bank AG - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Northern Trust Corp Grows Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 02, 2025
pulisher
May 28, 2025

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM)May 27, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire

May 28, 2025
pulisher
May 27, 2025

Shareholders of Actinium Pharmaceuticals, Inc. (ATNM): Protect Your Rights Before May 27, 2025Contact Levi & Korsinsky - ACCESS Newswire

May 27, 2025
pulisher
May 27, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - Business Wire

May 27, 2025
pulisher
May 26, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

May 26, 2025
pulisher
May 26, 2025

FINAL REMINDER ATNM DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Actinium Pharmaceuticals, Inc. Investors to Participate in the Class Action Lawsuit - ACCESS Newswire

May 26, 2025
pulisher
May 26, 2025

2025-05-26 | Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025Contact Levi & Korsinsky | NYSEAM:ATNM | Press Release - Stockhouse

May 26, 2025
pulisher
May 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesATNM - Eastern Progress

May 26, 2025
pulisher
May 26, 2025

ATNM Deadline: ATNM Investors with Losses in Excess of $100K Hav - GuruFocus

May 26, 2025
pulisher
May 26, 2025

ATNM Deadline: ATNM Investors with Losses in Excess of $100K Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit - Morningstar

May 26, 2025
pulisher
May 26, 2025

Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM)Join by May 27, 2025Contact Levi & Korsinsky - Stockhouse

May 26, 2025
pulisher
May 25, 2025

Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Contact Levi & Korsinsky to Join Class Action Before May 27, 2025 - ACCESS Newswire

May 25, 2025
pulisher
May 25, 2025

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, ... - Eagle-Tribune

May 25, 2025
pulisher
May 25, 2025

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, - GlobeNewswire

May 25, 2025
pulisher
May 25, 2025

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action – ATNM - GlobeNewswire Inc.

May 25, 2025
pulisher
May 25, 2025

Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. (ATNM) Shareholders of Class Action Lawsuit and May 27, 2025 Deadline - ACCESS Newswire

May 25, 2025
pulisher
May 25, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - StreetInsider

May 25, 2025
pulisher
May 24, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - StreetInsider

May 24, 2025
pulisher
May 23, 2025

ATNM Deadline: Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Joplin Globe

May 23, 2025
pulisher
May 22, 2025

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium LawsuitATNM - The Malaysian Reserve

May 22, 2025
pulisher
May 22, 2025

ATNM DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Shareholders that lost money on Actinium Pharmaceuticals, Inc. (ATNM) Urged to Join Class ... - Bluefield Daily Telegraph

May 22, 2025
pulisher
May 22, 2025

Shareholders that lost money on Actinium Pharmaceuticals, - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - marketscreener.com

May 22, 2025

Actinium Pharmaceuticals Inc (ATNM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
大文字化:     |  ボリューム (24 時間):